SPN and muscular dystrophy: Most commercial antibodies to SSPN are generated by antigens to human SSPN (hSSPN) and have a limited range of applications (Figure 1A–C; LS-N antibody as an example) which is a major limitation to pursuing basic and translational research in the muscular dystrophies.